16th World Clinical Biomarkers and Companion Diagnostics Summit - Massachusetts
October 5 - 8, 2026 - MA USHanson Wade
info@hansonwade.com
Phone:+1 617 455 4188
As IVD regulatory pathways continue to ease and $60B+ in diagnostic deal-making reshaping partnerships, it is clear precision medicine has entered a defining new phase. Against this backdrop, the landmark World Clinical Biomarkers and Companion Diagnostics Summit returns for its 16th edition from October 5-8, as the field's legacy forum, convening 850+ senior leaders at the forefront of precision medicine. Expanding to five content tracks, this year's agenda will reflect the scale and complexity of the field, delving into Biomarker Discovery and Translation, Clinical and CDx Development, and Rx-Dx Commercialization and Adoption, alongside Digital Pathology and Spatial Biomarkers and Multimodal and AI-Enabled Precision Medicine (both NEW for 2026). With free* tickets available for qualified biopharma, now is the time to return to the room uniting the creme-de-le-creme of precision medicine! Time: 8:30 AM - 2:50 PM